https://mdtechcouncil.com/maryland-tech-council-announces-2024-icon-award-finalists/
GlycoMantra received SBIR Phase 1 grant from the NCI (NIH)
July 18, 2018
GlycoMantra received SBIR Phase 1 grant from the NCI (NIH)
GlycoMantra was awarded SBIR Phase 1 grant to investigate drug resistance in metastatic prostate cancer.
